CSIMarket Company Name, Ticker, Suppliers, else..


Catalyst Pharmaceuticals Inc   (NASDAQ: CPRX)
Other Ticker:  
 

Catalyst Pharmaceuticals Inc

CPRX's Fundamental analysis



Looking into Catalyst Pharmaceuticals Inc growth rates, revenue grew by 25.33 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 576

Major Pharmaceutical Preparations industry recorded growth of revenues by 9.75 %

Catalyst Pharmaceuticals Inc realized net income compared to net loss a year ago in III. Quarter 2024

• More on CPRX's Growth


Catalyst Pharmaceuticals Inc
current PE on trailing twelve month basis is below Major Pharmaceutical Preparations industry average.

Catalyst Pharmaceuticals Inc PEG ratio is at 0.15 Company is currently trading with Price to Cash flow multiple of 8.89 in trailing twelve-month period.
Company
19.44
PE TTM   
Industry
595.15
PE TTM    
Company's Price to Sales ratio is at 6.2.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.88.


• More on CPRX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 4,344,170
 Net Income/Employee (TTM) $ 1,347,142
 Receivable Turnover (TTM) 8.03
 Tangible Book Value (Per Share $) 3.95

Catalyst Pharmaceuticals Inc
current PE on trailing twelve month basis is below Major Pharmaceutical Preparations industry average.

Catalyst Pharmaceuticals Inc PEG ratio is at 0.15 Company is currently trading with Price to Cash flow multiple of 8.89 in trailing twelve-month period.
Company
19.44
PE TTM   
Industry
595.15
PE TTM    
Company's Price to Sales ratio is at 6.2.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.88.

Catalyst Pharmaceuticals Inc Price to Book Ratio is at 4.32 lower than Industry Avg. of 827.77. and higher than S&P 500 Avg. of 0.01

• More on CPRX's Valuation

•  Market Capitalization (Millions $) 2,857
•  Shares Outstanding (Millions) 125
•  Employees 106
•  Revenues (TTM) (Millions $) 460
•  Net Income (TTM) (Millions $) 143
•  Cash Flow (TTM) (Millions $) 321
•  Capital Exp. (TTM) (Millions $) -1
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 4,344,170
•  Net Income/Employee(TTM) $ 1,347,142
•  Receivable Turnover Ratio (TTM) 8.03
•  Tangible Book Value (Per Share $) 3.95

•  Market Capitalization (Millions $) 2,857
•  Shares Outstanding (Millions) 125
•  Employees 106
•  Revenues (TTM) (Millions $) 460
•  Net Income (TTM) (Millions $) 143
•  Cash Flow (TTM) (Millions $) 321
•  Capital Exp. (TTM) (Millions $) -1


    CPRX's Profitability Comparisons
Catalyst Pharmaceuticals Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in III. Quarter 2024 to 39.56 % from 44.21 % in II. Quarter.

Catalyst Pharmaceuticals Inc net profit margin of 34.1 % is currently ranking no. 16 in Major Pharmaceutical Preparations industry, ranking no. 29 in Healthcare sector and number 275 in S&P 500.


Profitability by Segment
Total 34.1 %



  Ratio
•   Capital Ratio (MRQ) 5.11
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.22
•  Asset Turnover Ratio (TTM) 0.71
•  Inventory Turnover Ratio (TTM) 3.42



Catalyst Pharmaceuticals Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in III. Quarter 2024 to 39.56 % from 44.21 % in II. Quarter.

Catalyst Pharmaceuticals Inc net profit margin of 34.1 % is currently ranking no. 16 in Major Pharmaceutical Preparations industry, ranking no. 29 in Healthcare sector and number 275 in S&P 500.

• More on CPRX's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com